Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on E
Target Price
The average target price of DXR is 18.7 and suggests 86.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre